Prime Therapeutics hires new CIO to lead digital transformation
Dinesh Kandanchatha joined the organization
In this role, Kandanchatha will play a central role in shaping and executing Prime's information technology (IT) strategy, overseeing program delivery and providing operational support. He will lead IT planning for the delivery of information systems – including security and efficiency of IT operations.
"Efficient, quality and compliant technology is foundational to our industry and our organization," said
Kandanchatha has more than 25 years of technology leadership, and was most recently managing partner, HealthTech and Life Sciences at Emids, a leader in technology-led transformation and digital engineering solutions for the health care industry. At Emids, Kandanchatha was responsible for strategy and operations for engineering, cloud, design and data for pharmacy benefit managers (PBMs) and other specialty health record systems. Before that, Kandanchatha's entrepreneurial background was honed by previous work focused on building up several start-ups by bringing their technology to scale, including Patriot One Technologies, where he was a founder.
Kandanchatha has both bachelor's and master's degrees from the University of Ottawa in
About Prime Therapeutics + Magellan Rx
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.
Contact: |
|
View original content:https://www.prnewswire.com/news-releases/prime-therapeutics-hires-new-cio-to-lead-digital-transformation-302190190.html
SOURCE Prime Therapeutics LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultra Violette Becomes First Brand in the US to Launch a Sunscreen Containing Newly FDA-Approved Filter Bemotrizinol
- Tusayan, Arizona Remains Fully Operational and Unaffected as recovery efforts from recent flooding continue in affected areas of the Grand Canyon National Park
- Leadership Expert David Grossman Available to Discuss EY’s $100 Million Bet on ‘Human’ Skills
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share